wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26827975-2B93CFB0-724E-4A87-8A79-A99062C710B0
Q26827975-2B93CFB0-724E-4A87-8A79-A99062C710B0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26827975-2B93CFB0-724E-4A87-8A79-A99062C710B0
Growth factor and signaling pathways and their relevance to prostate cancer therapeutics
P2860
Q26827975-2B93CFB0-724E-4A87-8A79-A99062C710B0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26827975-2B93CFB0-724E-4A87-8A79-A99062C710B0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8393c84968ea08309dcb1a0ce25ea2c8d460df7e
P2860
Phase II randomized, double-blind, placebo-controlled study of tasquinimod in men with minimally symptomatic metastatic castrate-resistant prostate cancer.